Taiwan Liposome
Taipei
About Taiwan Liposome
Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on its proprietary drug delivery technologies. Our strengths lie in lipid-based formulation and scale-up for parenteral drugs using micelles and nanoparticles to optimize the pharmacokinetics of drugs for better efficacy and lower toxicity, and thus prolong the product lifecycle of branded drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Funding stage: IPO
- Last round: Series A (Jul 2009)
- Ticker: nasdaq:TLC
- Website: tlcbio.com
- Phone: 886 2 2655 7377
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/taiwan-liposome-132454 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.